B Plus
B Plus, licence 80022184: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- B Plus 500
- Licence holder
- Canada Optimal Nature Inc.
- NPN or DIN-HM
- 80022184
- Status
- Active licence
- Licence date
- 8 November 2010
- Revision date
- 30 November 2010
- Form
- Gélule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Conditions légales
Linum usitatissimum L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Linum usitatissimum Source : Linum usitatissimum - Graine | 0.5 g | Not calculated |
| Linum usitatissimum Source : Linum usitatissimum - Graine | 500.0 mg | Not calculated |
Non-medicinal ingredients
Gélatine, Eau purifiée, Glycérine, Extrait de bleuet
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et adolescents | minimum: 15.0 Année(s) | 1.0 Capsule | 2.0 Jour(s) |
| Enfants et Adolescents | minimum: 5.0 Année(s) ; maximum: 9.0 Année(s) | 1.0 Capsule | 2.0 Jour(s) |
| Enfants | minimum: 2.0 Année(s) ; maximum: 4.0 Année(s) | 1.0 Capsule | 2.0 Jour(s) |
| Adultes, adolescents et enfants | maximum: 50.0 Année(s) | 1.0 Capsule | 2.0 Jour |
| Adultes | minimum: 51.0 Année(s) | 1.0 Capsule | 2.0 Jour |
| Adolescentes | minimum: 10.0 Année(s) ; maximum: 14.0 Année(s) | 1.0 Capsule | 2.0 Jour(s) |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of essential fatty acids for the maintenance of good health.
Source of alpha-linolenic acid (ALA) for the maintenance of good health.
Source of omega-3 fatty acids for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80022184
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2010. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.